Titolo	Data di pubblicazione	Autore(i)
1	Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells	2012	I. Campia; J. Kopecka; B. Castella; M. Rigoni; M. Coscia; A. Bosia; D. Ghigo; M. Massaia; C. Riganti
2	Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells	2013	C. Riganti; B. Castella; J. Kopecka; I. Campia; M. Coscia; G. Pescarmona; A. Bosia; D. Ghigo; M. Massaia
3	Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression	2018	Barbara Castella, Myriam Foglietta, Chiara Riganti, Massimo Massaia
4	Vγ9Vδ2 T cells as strategic weapons to improve the potency of immune checkpoint blockade and immune interventions in human myeloma	2018	Barbara Castella, Assunta Melaccio, Myriam Foglietta, Chiara Riganti, Massimo Massaia
5	Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside	2011	Castella B; Vitale C; Coscia M; Massaia M
6	The tryptophan metabolism in the immune dysregulation of multiple myeloma	2007	Fiore F, Castella B, Assalto C, Zappia S, Hwang SY, Vitale C, Boccadoro M, Massaia M
7	The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL)	2012	Micol Rigoni; Marta Coscia; Chiara Riganti; Ivana Campia; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
8	The Mevalonate Pathway As a Metabolic Target to Circumvent Multidrug-Resistance in Chronic Lymphocytic Leukemia Cells	2011	Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Valentina Griggio; Silvia Peola; Barbara Castella; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
9	The Mevalonate Pathway and Downstream Signal Transducers As Therapeutic Targets to Overcome Multidrug Resistance in Chronic Lymphocytic Leukemia (CLL)	2012	Marta Coscia; Micol Rigoni; Chiara Riganti; Candida Vitale; Ivana Campia; Valentina Griggio; Myriam Foglietta; Barbara Castella; Patrizia Sciancalepore; Maria Elisa Canepari; Marta Robino; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
10	The association of dexamethasone + simvastatin to overcome environment-mediated chemoresistance of chronic lymphocytic leukemia (CLL) cells	2014	Rigoni M; Riganti C; Griggio V; Coscia M; Castella B; Foglietta M; Vitale C; Sciancalepore P; Robino M; Boccadoro M; Massaia M
11	Targeting the mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells	2011	Rigoni M; Coscia M; Riganti C; Campia I; Vitale C; Peola S; Castella B; Griggio V; Pantaleoni F; Sciancalepore P; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
12	TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS	2016	Vitale, C; Griggio, V; Todaro, M; Riganti, C; Salaroglio, IC; Salvetti, C; Rigoni, M; Foglietta, M; Castella, B; Boccadoro, M; Massaia, M; Coscia, M
13	Targeting mevalonate pathway down-regulates ABCB1, reversing chemoresistance and immunoresistance in human cancer cells.	2012	Joanna Kopecka; Ivana Campia; Barbara Castella; Massimo Massaia; Chiara Riganti
14	TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA	2017	Vitale, C; Griggio, V; Todaro, M; Riganti, C; Salaroglio, IC; Salvetti, C; Rigoni, M; Foglietta, M; Castella, B; Boccadoro, M; Massaia, M; Coscia, M
15	TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA	2017	Vitale, C; Griggio, V; Todaro, M; Riganti, C; Salaroglio, IC; Salvetti, C; Rigoni, M; Foglietta, M; Castella, B; Boccadoro, M; Massaia, M; Coscia, M
16	Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells	2015	Rigoni, Micol; Riganti, Chiara; Vitale, Candida; Griggio, Valentina; Campia, Ivana; Robino, Marta; Foglietta, Myriam; Castella, Barbara; Sciancalepore, Patrizia; Buondonno, Ilaria; Drandi, Daniela; Ladetto, Marco; Boccadoro, Mario; Massaia, Massimo; Coscia, Marta
17	SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THEIDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENS INCHRONIC LYMPHOCYTIC LEUKEMIA	2011	M. Coscia; V. Griggio; M. Capello; F. Linty; C. Vitale; S. Peola; B. Castella; M. Rigoni; D. Drandi; M. Ruggeri; P. Omede`; M. Ladetto; F. Novelli; M. Boccadoro; M. Massaia
18	SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA	2011	M. Coscia; V. Griggio; M. Capello; F. Linty; C. Vitale; S. Peola; P. Cappello; B. Castella; M. Rigoni; P. Sciancalepore; D. Drandi; M. Ruggeri; P. Omedè; M. Ladetto; F. Novelli; M. Boccadoro; M. Massaia
19	Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL)	2012	Valentina Griggio; Michela Capello; Candida Vitale; Federica Linty; Paola Cappello; Giorgia Mandili; Barbara Castella; Myriam Foglietta; Micol Rigoni; Patrizia Sciancalepore; Daniela Drandi; Marina Ruggeri; Paola Omedé; Marco Ladetto; Francesco Novelli; Mario Boccadoro; Massimo Massaia; Marta Coscia
20	ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID	2004	Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M